A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study

Conclusions: Concurrent cisplatin-based chemotherapy administered weekly or three-weekly in combination with IMRT leads to similar acute toxicities and long-term survival outcomes in locoregionally advanced NPC patients.

Source: Journal of Cancer - June 20, 2018 Category: Cancer & Oncology Authors: Dong-Fang Meng, Rui Sun, Li-Xia Peng, You-Sheng Huang, Qin Yang, Dong-Hua Luo, Wei-Han Hu, Fang-Yun Xie, Wei Luo, Chong Zhao, Ling Guo, Hai-Qiang Mai, Ming-Yuan Chen, Ping Xie, Li-Sheng Zheng, Jun-Ping Yang, Yan Mei, Yuan-Yuan Qiang, Liang Xu, Chang-Zhi L Tags: Research Paper Source Type: research